nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC46A1—Pemetrexed—lung cancer	0.273	0.487	CbGbCtD
Sulfasalazine—ABCG2—lung cancer	0.182	0.671	CbGaD
Sulfasalazine—PTGS2—lung cancer	0.0889	0.329	CbGaD
Sulfasalazine—SLC46A1—Methotrexate—lung cancer	0.0463	0.0828	CbGbCtD
Sulfasalazine—ABCG2—Topotecan—lung cancer	0.017	0.0304	CbGbCtD
Sulfasalazine—ABCG2—Gefitinib—lung cancer	0.0155	0.0278	CbGbCtD
Sulfasalazine—ABCG2—Teniposide—lung cancer	0.0151	0.0269	CbGbCtD
Sulfasalazine—SLCO1B1—Irinotecan—lung cancer	0.0104	0.0187	CbGbCtD
Sulfasalazine—ABCC2—Paclitaxel—lung cancer	0.0093	0.0166	CbGbCtD
Sulfasalazine—ABCG2—Erlotinib—lung cancer	0.00918	0.0164	CbGbCtD
Sulfasalazine—ABCC2—Irinotecan—lung cancer	0.00917	0.0164	CbGbCtD
Sulfasalazine—CYP3A5—Gefitinib—lung cancer	0.00861	0.0154	CbGbCtD
Sulfasalazine—ABCG2—Paclitaxel—lung cancer	0.00841	0.015	CbGbCtD
Sulfasalazine—CYP3A5—Teniposide—lung cancer	0.00834	0.0149	CbGbCtD
Sulfasalazine—ABCG2—Irinotecan—lung cancer	0.00829	0.0148	CbGbCtD
Sulfasalazine—ABCC2—Vinblastine—lung cancer	0.00816	0.0146	CbGbCtD
Sulfasalazine—ABCC2—Cisplatin—lung cancer	0.00748	0.0134	CbGbCtD
Sulfasalazine—PTGS2—Cisplatin—lung cancer	0.00739	0.0132	CbGbCtD
Sulfasalazine—ABCC2—Etoposide—lung cancer	0.00735	0.0131	CbGbCtD
Sulfasalazine—PTGS2—Etoposide—lung cancer	0.00726	0.013	CbGbCtD
Sulfasalazine—ABCG2—Cisplatin—lung cancer	0.00676	0.0121	CbGbCtD
Sulfasalazine—ABCC2—Docetaxel—lung cancer	0.00672	0.012	CbGbCtD
Sulfasalazine—ABCG2—Etoposide—lung cancer	0.00664	0.0119	CbGbCtD
Sulfasalazine—PTGS1—Etoposide—lung cancer	0.00613	0.011	CbGbCtD
Sulfasalazine—ABCG2—Docetaxel—lung cancer	0.00608	0.0109	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—lung cancer	0.00552	0.00988	CbGbCtD
Sulfasalazine—CYP3A5—Crizotinib—lung cancer	0.00527	0.00943	CbGbCtD
Sulfasalazine—CYP3A5—Erlotinib—lung cancer	0.00509	0.0091	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—lung cancer	0.00501	0.00896	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—lung cancer	0.00485	0.00868	CbGbCtD
Sulfasalazine—CYP3A5—Paclitaxel—lung cancer	0.00466	0.00833	CbGbCtD
Sulfasalazine—CYP3A5—Irinotecan—lung cancer	0.00459	0.00822	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—lung cancer	0.00453	0.0081	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—lung cancer	0.00439	0.00785	CbGbCtD
Sulfasalazine—CYP3A5—Etoposide—lung cancer	0.00368	0.00658	CbGbCtD
Sulfasalazine—CYP3A5—Docetaxel—lung cancer	0.00337	0.00602	CbGbCtD
Sulfasalazine—TBXAS1—mammary gland—lung cancer	0.0028	0.0702	CbGeAlD
Sulfasalazine—ACAT1—respiratory system—lung cancer	0.00224	0.056	CbGeAlD
Sulfasalazine—TBXAS1—respiratory system—lung cancer	0.00187	0.0468	CbGeAlD
Sulfasalazine—ACAT1—bronchus—lung cancer	0.00184	0.0461	CbGeAlD
Sulfasalazine—PLA2G1B—respiratory system—lung cancer	0.00157	0.0392	CbGeAlD
Sulfasalazine—ACAT1—cardiac atrium—lung cancer	0.00155	0.0388	CbGeAlD
Sulfasalazine—CHUK—epithelium—lung cancer	0.00139	0.0348	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—lung cancer	0.00131	0.0328	CbGeAlD
Sulfasalazine—PLA2G1B—epithelium—lung cancer	0.00131	0.0328	CbGeAlD
Sulfasalazine—SLCO1B1—mammary gland—lung cancer	0.00123	0.0307	CbGeAlD
Sulfasalazine—ACAT1—lung—lung cancer	0.00119	0.0297	CbGeAlD
Sulfasalazine—IKBKB—respiratory system—lung cancer	0.00113	0.0283	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—lung cancer	0.0011	0.0274	CbGeAlD
Sulfasalazine—PPARG—mammary gland—lung cancer	0.00106	0.0265	CbGeAlD
Sulfasalazine—TBXAS1—lung—lung cancer	0.000992	0.0248	CbGeAlD
Sulfasalazine—ALOX5—respiratory system—lung cancer	0.000939	0.0235	CbGeAlD
Sulfasalazine—IKBKB—bronchus—lung cancer	0.000932	0.0233	CbGeAlD
Sulfasalazine—CHUK—lung—lung cancer	0.000885	0.0221	CbGeAlD
Sulfasalazine—PPARG—Irinotecan—Topotecan—lung cancer	0.000881	0.33	CbGdCrCtD
Sulfasalazine—PLA2G1B—lung—lung cancer	0.000832	0.0208	CbGeAlD
Sulfasalazine—ACAT1—lymph node—lung cancer	0.000812	0.0203	CbGeAlD
Sulfasalazine—ALOX5—bronchus—lung cancer	0.000772	0.0193	CbGeAlD
Sulfasalazine—PPARG—Topotecan—Irinotecan—lung cancer	0.000732	0.274	CbGdCrCtD
Sulfasalazine—SLC7A11—lung—lung cancer	0.000728	0.0182	CbGeAlD
Sulfasalazine—PPARG—Etoposide—Teniposide—lung cancer	0.000728	0.272	CbGdCrCtD
Sulfasalazine—PPARG—respiratory system—lung cancer	0.000705	0.0176	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—lung cancer	0.000679	0.017	CbGeAlD
Sulfasalazine—CHUK—lymph node—lung cancer	0.000605	0.0151	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—lung cancer	0.000605	0.0151	CbGeAlD
Sulfasalazine—IKBKB—lung—lung cancer	0.000601	0.015	CbGeAlD
Sulfasalazine—PPARG—epithelium—lung cancer	0.000589	0.0147	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—lung cancer	0.00055	0.0138	CbGeAlD
Sulfasalazine—ALOX5—lung—lung cancer	0.000498	0.0125	CbGeAlD
Sulfasalazine—Vismodegib—ABCG2—lung cancer	0.000467	0.217	CrCbGaD
Sulfasalazine—CYP3A5—respiratory system—lung cancer	0.000419	0.0105	CbGeAlD
Sulfasalazine—PPARG—bone marrow—lung cancer	0.000413	0.0103	CbGeAlD
Sulfasalazine—IKBKB—lymph node—lung cancer	0.000411	0.0103	CbGeAlD
Sulfasalazine—Sulfaphenazole—CYP2A6—lung cancer	0.000404	0.188	CrCbGaD
Sulfasalazine—PTGS1—respiratory system—lung cancer	0.000377	0.00943	CbGeAlD
Sulfasalazine—PPARG—lung—lung cancer	0.000374	0.00936	CbGeAlD
Sulfasalazine—PTGS2—respiratory system—lung cancer	0.00036	0.00901	CbGeAlD
Sulfasalazine—ALOX5—lymph node—lung cancer	0.000341	0.00853	CbGeAlD
Sulfasalazine—PPARG—Teniposide—Etoposide—lung cancer	0.00033	0.124	CbGdCrCtD
Sulfasalazine—PTGS1—epithelium—lung cancer	0.000315	0.00788	CbGeAlD
Sulfasalazine—Sulfadiazine—CYP2E1—lung cancer	0.000314	0.146	CrCbGaD
Sulfasalazine—Balsalazide—PTGS2—lung cancer	0.000307	0.143	CrCbGaD
Sulfasalazine—PTGS2—epithelium—lung cancer	0.000301	0.00753	CbGeAlD
Sulfasalazine—PTGS2—bronchus—lung cancer	0.000296	0.00742	CbGeAlD
Sulfasalazine—PTGS1—trachea—lung cancer	0.000278	0.00697	CbGeAlD
Sulfasalazine—PTGS2—trachea—lung cancer	0.000266	0.00666	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—lung cancer	0.000265	0.00662	CbGeAlD
Sulfasalazine—PTGS1—cardiac atrium—lung cancer	0.000262	0.00654	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—lung cancer	0.000261	0.121	CrCbGaD
Sulfasalazine—PPARG—lymph node—lung cancer	0.000256	0.0064	CbGeAlD
Sulfasalazine—ABCG2—lung—lung cancer	0.00024	0.006	CbGeAlD
Sulfasalazine—ABCC2—lymph node—lung cancer	0.000225	0.00563	CbGeAlD
Sulfasalazine—CYP3A5—lung—lung cancer	0.000223	0.00557	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—lung cancer	0.000211	0.00528	CbGeAlD
Sulfasalazine—Vismodegib—ALB—lung cancer	0.000204	0.0947	CrCbGaD
Sulfasalazine—PTGS1—lung—lung cancer	0.0002	0.00501	CbGeAlD
Sulfasalazine—Vismodegib—ABCB1—lung cancer	0.000195	0.0904	CrCbGaD
Sulfasalazine—PTGS2—lung—lung cancer	0.000191	0.00478	CbGeAlD
Sulfasalazine—ABCG2—lymph node—lung cancer	0.000164	0.00411	CbGeAlD
Sulfasalazine—PTGS1—lymph node—lung cancer	0.000137	0.00342	CbGeAlD
Sulfasalazine—PTGS2—lymph node—lung cancer	0.000131	0.00327	CbGeAlD
Sulfasalazine—CHUK—Immune System—JUN—lung cancer	2.91e-06	2.32e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—STK11—lung cancer	2.9e-06	2.31e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.89e-06	2.31e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.89e-06	2.3e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB3—lung cancer	2.88e-06	2.29e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGFR1—lung cancer	2.87e-06	2.29e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—lung cancer	2.86e-06	2.28e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTP1—lung cancer	2.85e-06	2.27e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HIF1A—lung cancer	2.83e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDKN1A—lung cancer	2.82e-06	2.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTEN—lung cancer	2.81e-06	2.24e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOA1—lung cancer	2.8e-06	2.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—lung cancer	2.78e-06	2.22e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAT—lung cancer	2.78e-06	2.21e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.76e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TERT—lung cancer	2.76e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CG—lung cancer	2.76e-06	2.2e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APC—lung cancer	2.75e-06	2.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CG—lung cancer	2.75e-06	2.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—lung cancer	2.75e-06	2.19e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—lung cancer	2.75e-06	2.19e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—lung cancer	2.74e-06	2.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOA1—lung cancer	2.73e-06	2.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGF—lung cancer	2.72e-06	2.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—lung cancer	2.71e-06	2.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KDR—lung cancer	2.71e-06	2.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCB1—lung cancer	2.7e-06	2.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOA1—lung cancer	2.69e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EP300—lung cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CB—lung cancer	2.68e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—lung cancer	2.68e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGFR1—lung cancer	2.68e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—lung cancer	2.67e-06	2.13e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—lung cancer	2.66e-06	2.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TYMS—lung cancer	2.65e-06	2.11e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PIK3CA—lung cancer	2.64e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HIF1A—lung cancer	2.64e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JUN—lung cancer	2.64e-06	2.1e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—POMC—lung cancer	2.62e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—lung cancer	2.62e-06	2.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—POMC—lung cancer	2.62e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SRC—lung cancer	2.61e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAT—lung cancer	2.61e-06	2.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1A—lung cancer	2.6e-06	2.07e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTEN—lung cancer	2.6e-06	2.07e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—BRAF—lung cancer	2.58e-06	2.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.57e-06	2.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1A—lung cancer	2.56e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CREBBP—lung cancer	2.56e-06	2.04e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CG—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6R—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CREBBP—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MAPK3—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOA1—lung cancer	2.55e-06	2.03e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCB1—lung cancer	2.54e-06	2.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—lung cancer	2.53e-06	2.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—lung cancer	2.52e-06	2e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NRAS—lung cancer	2.51e-06	2e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—lung cancer	2.49e-06	1.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CG—lung cancer	2.49e-06	1.98e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APC—lung cancer	2.49e-06	1.98e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TYMS—lung cancer	2.49e-06	1.98e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP1A1—lung cancer	2.49e-06	1.98e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EP300—lung cancer	2.48e-06	1.97e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—lung cancer	2.48e-06	1.97e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ERCC2—lung cancer	2.47e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGF—lung cancer	2.46e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—lung cancer	2.46e-06	1.96e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CG—lung cancer	2.45e-06	1.95e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EP300—lung cancer	2.43e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAP2K1—lung cancer	2.43e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—POMC—lung cancer	2.43e-06	1.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—lung cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CD—lung cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CD—lung cancer	2.42e-06	1.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SRC—lung cancer	2.41e-06	1.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK3—lung cancer	2.4e-06	1.92e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—lung cancer	2.39e-06	1.91e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—POMC—lung cancer	2.37e-06	1.89e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SRC—lung cancer	2.37e-06	1.88e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CREBBP—lung cancer	2.37e-06	1.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BRAF—lung cancer	2.34e-06	1.87e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP1A1—lung cancer	2.34e-06	1.86e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—POMC—lung cancer	2.33e-06	1.86e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—lung cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APC—lung cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—lung cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NRAS—lung cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTEN—lung cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ERCC2—lung cancer	2.32e-06	1.84e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6R—lung cancer	2.31e-06	1.84e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CREBBP—lung cancer	2.31e-06	1.84e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGF—lung cancer	2.3e-06	1.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—lung cancer	2.29e-06	1.82e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—lung cancer	2.28e-06	1.82e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NRAS—lung cancer	2.28e-06	1.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CREBBP—lung cancer	2.27e-06	1.81e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CD—lung cancer	2.24e-06	1.79e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK3—lung cancer	2.22e-06	1.77e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—lung cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—EP300—lung cancer	2.21e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAP2K1—lung cancer	2.21e-06	1.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CD—lung cancer	2.19e-06	1.74e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BRAF—lung cancer	2.19e-06	1.74e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK3—lung cancer	2.18e-06	1.74e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KRAS—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6R—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RAF1—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CD—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CREBBP—lung cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ERBB2—lung cancer	2.13e-06	1.7e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOA1—lung cancer	2.13e-06	1.7e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—lung cancer	2.13e-06	1.7e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CB—lung cancer	2.11e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—lung cancer	2.11e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MTOR—lung cancer	2.11e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CB—lung cancer	2.11e-06	1.68e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—lung cancer	2.09e-06	1.67e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—lung cancer	2.07e-06	1.65e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAP2K1—lung cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CD—lung cancer	2.04e-06	1.63e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.04e-06	1.63e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL8—lung cancer	2.02e-06	1.61e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOA1—lung cancer	2e-06	1.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KRAS—lung cancer	2e-06	1.59e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3CA—lung cancer	1.99e-06	1.58e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—lung cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KRAS—lung cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CB—lung cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RAF1—lung cancer	1.96e-06	1.56e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CG—lung cancer	1.95e-06	1.55e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—lung cancer	1.94e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—lung cancer	1.94e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ERBB2—lung cancer	1.93e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—lung cancer	1.93e-06	1.54e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CB—lung cancer	1.91e-06	1.52e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MTOR—lung cancer	1.91e-06	1.52e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—lung cancer	1.89e-06	1.5e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUN—lung cancer	1.88e-06	1.5e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CB—lung cancer	1.88e-06	1.5e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—lung cancer	1.86e-06	1.48e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—POMC—lung cancer	1.85e-06	1.48e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—lung cancer	1.84e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL8—lung cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3CA—lung cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—lung cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—lung cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CG—lung cancer	1.83e-06	1.46e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—lung cancer	1.83e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—RAF1—lung cancer	1.82e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1A—lung cancer	1.82e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—lung cancer	1.82e-06	1.45e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CREBBP—lung cancer	1.81e-06	1.44e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB2—lung cancer	1.81e-06	1.44e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3CA—lung cancer	1.8e-06	1.43e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTOR—lung cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CB—lung cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—lung cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—lung cancer	1.76e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—lung cancer	1.76e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—lung cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—POMC—lung cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—EP300—lung cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EP300—lung cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—lung cancer	1.72e-06	1.37e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CD—lung cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—lung cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUN—lung cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—lung cancer	1.7e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CREBBP—lung cancer	1.7e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—lung cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—lung cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SRC—lung cancer	1.69e-06	1.34e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—lung cancer	1.67e-06	1.33e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—lung cancer	1.66e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1A—lung cancer	1.65e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—lung cancer	1.65e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—lung cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CA—lung cancer	1.64e-06	1.3e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—lung cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NRAS—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—lung cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—EP300—lung cancer	1.61e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CD—lung cancer	1.61e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—lung cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—lung cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EP300—lung cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK3—lung cancer	1.55e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—EP300—lung cancer	1.55e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1A—lung cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTEN—lung cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SRC—lung cancer	1.53e-06	1.22e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—lung cancer	1.51e-06	1.2e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—lung cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CB—lung cancer	1.49e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—lung cancer	1.49e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—lung cancer	1.48e-06	1.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—lung cancer	1.48e-06	1.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NRAS—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EP300—lung cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SRC—lung cancer	1.43e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK3—lung cancer	1.41e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CB—lung cancer	1.4e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KRAS—lung cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—lung cancer	1.39e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—lung cancer	1.38e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NRAS—lung cancer	1.37e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—lung cancer	1.37e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—lung cancer	1.34e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—lung cancer	1.34e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK3—lung cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—lung cancer	1.29e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.29e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CA—lung cancer	1.28e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—lung cancer	1.28e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KRAS—lung cancer	1.27e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—lung cancer	1.25e-06	9.96e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—lung cancer	1.24e-06	9.89e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—EP300—lung cancer	1.23e-06	9.79e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—lung cancer	1.21e-06	9.64e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CA—lung cancer	1.19e-06	9.5e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—lung cancer	1.19e-06	9.46e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KRAS—lung cancer	1.18e-06	9.41e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CA—lung cancer	1.16e-06	9.27e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—EP300—lung cancer	1.15e-06	9.2e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CA—lung cancer	1.15e-06	9.12e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—lung cancer	1.14e-06	9.05e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—lung cancer	1.13e-06	8.97e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CA—lung cancer	1.09e-06	8.65e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—lung cancer	1.08e-06	8.58e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—lung cancer	1.05e-06	8.38e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—lung cancer	1.05e-06	8.35e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—lung cancer	1.03e-06	8.21e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—lung cancer	1e-06	8e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—lung cancer	9.74e-07	7.76e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—lung cancer	9.62e-07	7.66e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—lung cancer	9.51e-07	7.57e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—lung cancer	9.36e-07	7.45e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CA—lung cancer	9.09e-07	7.24e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—lung cancer	8.87e-07	7.06e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CA—lung cancer	8.54e-07	6.8e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—lung cancer	7.43e-07	5.92e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—lung cancer	6.98e-07	5.56e-06	CbGpPWpGaD
